Eidos Therapeutics, Inc. Business Finance Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Loan Modification Agreement among Silicon Valley Bank, Hercules Capital, Inc., and Eidos Therapeutics, Inc.
Modification Agreements
Eidos Therapeutics, Inc.
Biotechnology
DE
2021
Description of Eidos Therapeutics, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Eidos Therapeutics, Inc.
Biotechnology
DE
2020
Eidos Therapeutics, Inc. Amended and Restated 2016 Equity Incentive Plan
Equity Distribution Agreements
Eidos Therapeutics, Inc.
Biotechnology
DE
2018
Eidos Therapeutics, Inc. Underwriting Agreement with J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated
Underwriting Agreements
Eidos Therapeutics, Inc.
Biotechnology
NY
2018
Eidos Therapeutics, Inc. Amended and Restated 2016 Equity Incentive Plan
Equity Distribution Agreements
Eidos Therapeutics, Inc.
Biotechnology
DE
2018
Loan and Security Agreement among Silicon Valley Bank, Hercules Capital, Inc., and Eidos Therapeutics, Inc. dated November 13, 2019
Loan Agreements
Eidos Therapeutics, Inc.
Biotechnology
CA
2019
Non-Qualified Stock Option Agreement for Consultants under Eidos Therapeutics, Inc. 2018 Stock Option and Incentive Plan
Warrant Agreements
Eidos Therapeutics, Inc.
Biotechnology
2019
Eidos Therapeutics, Inc. Warrant to Purchase Shares Agreement with BridgeBio Pharma LLC
Warrant Agreements
Eidos Therapeutics, Inc.
Biotechnology
CA
2018
Eidos Therapeutics, Inc. Common Stock Certificate Specimen
Stock Agreements
Eidos Therapeutics, Inc.
Biotechnology
2018
Eidos Therapeutics, Inc. $10,000,000 Convertible Promissory Note to BridgeBio Pharma LLC (February 22, 2018)
Note Agreements
Eidos Therapeutics, Inc.
Biotechnology
CA
2018
Eidos Therapeutics, Inc. Amended and Restated Investors' Rights Agreement (March 29, 2018)
Investor Rights Agreements
Eidos Therapeutics, Inc.
Biotechnology
DE
2018